BCYC 241220 17.50P (BCYC241220P17500) Stock Options, News & Quotes

US OptionsDetailed Quotes

BCYC241220P17500

Watchlist

4.72
+2.77+142.05%

15min DelayClose Dec 13 16:00 ET

4.72High4.72Low

Intraday

5D
Daily

News

Morgan Stanley Maintains Bicycle Therapeutics(BCYC.US) With Hold Rating, Maintains Target Price $30
Moomoo News18:31 ET · Ratings
Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall Response Rate In Urothelial Cancer Patients
BenzingaDec 13 07:50 ET
Needham Maintains Bicycle Therapeutics(BCYC.US) With Buy Rating, Cuts Target Price to $32
Moomoo News16:32 ET · Ratings
ADRs End Higher; WISeKey International Holding Ltd. Climbs 139%
Dow Jones16:31 ET
Sector Update: Health Care Stocks Edge Higher Late Afternoon
MT Newswires15:59 ET
Sector Update: Health Care
MT Newswires15:32 ET

Comments

Meltyy

May 16 01:14

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...

Meltyy

Apr 2 22:13

Gear up for AACR24!

See Biotech companies with cancer assets 👇
⇨ held by 5 biopharma-focused hedge funds! 🔥
$Arcellx (ACLX.US)$ : Anito-cel (Ph 2)
$Adaptimmune Therapeutics (ADAP.US)$ : Afami-cel (PDUFA) ⏳
$Bicycle Therapeutics (BCYC.US)$ : BT8009 (Ph 1/2)
$Centessa Pharmaceuticals (CNTA.US)$ : LB101 (Ph 1/2)
$Day One Biopharmaceuticals (DAWN.US)$ : Tovorafenib (PDUFA) (check comments for details)
$Fate Therapeutics (FATE.US)$ : FT576 (Ph 1)
$Fusion Pharmaceuticals (FUSN.US)$ : FPI-2265 (Ph 2)
$GRCL: ...

Trytosaveabit

Oct 19, 2023 06:28

NEWS!

$Bicycle Therapeutics (BCYC.US)$Moomoo 24/7· 1 min ago
Bicycle Therapeutics' Lead Candidate BT8009 For Metastatic Bladder (Urothelial) Cancer, Has Been Selected For Chemistry, Manufacturing And Controls Development And Readiness Pilot Program Launched By FDA

Weight-loss drugmakers report strong earnings: Boon or bane?

Moomoo Breakfast US

Sep 7, 2022 07:54

Columns Today's Pre-Market Stock Movers: NIO, PATH, COUP, RKLB and More

Gapping up
In reaction to earnings/guidance:
• $Coupa Software (COUP.US)$ +12% (also authorizes new $100mln share repurchase program), $REV Group (REVG.US)$ -5%, $G-III Apparel Group (GIII.US)$ + 2.1%, $Gitlab (GTLB.US)$ +1.2%
Other news:
• $Tupperware Brands (TUP.US)$ +6.7% (recovers a bit after falling -33% during regular session)
• $Avaya Holdings (AVYA.US)$ +6.6% (authorizes workforce reduction plan)
• $Bassett Furniture Industries (BSET.US)$ +5% (acqu...

Moomoo Breakfast US

May 27, 2022 07:17

Columns Today's pre-market stock movers: DELL, ULTA, COST, GPS and more

Gainer:
• $Red Robin (RRGB.US)$ +13.8% (In reaction to earnings)
• $PMV Pharmaceuticals (PMVP.US)$ +11.2% (ASCO-related announcement)
• $Sumo Logic (SUMO.US)$ +10.8% (In reaction to earnings)
• $Adicet Bio (ACET.US)$ +9.6% (ASCO-related announcement)
• $Dell Technologies (DELL.US)$ +9.6% (In reaction to earnings)
• $ImmunoGen (IMGN.US)$ +8.7% (ASCO-related announcement)
• $Ulta Beauty (ULTA.US)$ +7.9% (In reaction to earnings)
• $Zymergen (ZY.US)$ +7.8% (to...